Finland Biotechnology Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Biotechnology
Nanoform Finland PLC (STU:4YL) Q1 2025 Earnings Call Highlights: Strategic Growth and Market Expansion
Nanoform Finland PLC (STU:4YL) reports strong project growth and financial stability, while navigating challenges in market partnerships and revenue projections. May 21, 2025
Biotechnology
Herantis Pharma PLC (OHEL:HRTIS) (FY 2024) Earnings Call Highlights: Strategic Funding and Clinical Progress in Parkinson's Research
Herantis Pharma PLC (OHEL:HRTIS) secures significant funding and advances its promising Parkinson's treatment, HER-096, amidst a challenging market landscape. Apr 21, 2025
Biotechnology
Nanoform Finland PLC (STU:4YL) Q4 2024 Earnings Call Highlights: Record Project Signings and Strategic Market Expansion
Nanoform Finland PLC (STU:4YL) reports an 8% revenue growth, a record number of new projects, and entry into the Japanese market, setting the stage for future growth. Feb 28, 2025
Biotechnology
Faron Pharmaceuticals Oy (FRA:4FR) Full Year 2024 Earnings Call Highlights: Financial Gains and Strategic Advances Amid Challenges
Faron Pharmaceuticals Oy (FRA:4FR) reports improved cash position and reduced losses, while navigating regulatory and commercialization hurdles. Feb 28, 2025
Biotechnology
Nanoform Finland PLC (FRA:4YL) Q3 2024 Earnings Call Highlights: Record Deals and Improved Margins Signal Growth
Nanoform Finland PLC (FRA:4YL) reports a strong quarter with record deal signings, improved gross margins, and a robust financial position, despite challenges in the biotech funding environment. Nov 19, 2024
Biotechnology
Nanoform Finland PLC (STU:4YL) Q2 2024 Earnings Call Transcript Highlights: Key Takeaways and Future Outlook
Nanoform Finland PLC (STU:4YL) reports steady progress with significant milestones and strategic partnerships. Aug 30, 2024
Biotechnology
Faron Pharmaceuticals Oy (FRA:4FR) (Q2 2024) Earnings Call Transcript Highlights: Key Financial and Operational Updates
Faron Pharmaceuticals Oy (FRA:4FR) reports strong fundraising efforts and positive trial results amidst financial challenges. Aug 29, 2024
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers